Spontaneous intracranial hemorrhage in a patient with Middle East respiratory syndrome corona virus

References

1. ↵
   1. Van Boheemen S,
   2. de Graaf M,
   3. Lauber C,
   4. Bestebroer TM,
   5. Raj VS,
   6. Zaki AM,
   7. et al.

   (2012) Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio 3:473–412.

   OpenUrl
2. ↵
   1. Zaki AM,
   2. van Boheemen S,
   3. Bestebroer TM,
   4. Osterhaus AD,
   5. Fouchier RA

   (2012) Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 8(367):1814–1820.

   OpenUrl
3. ↵
   1. World Health Orgnization: Middle East respiratory syndrome coronavirus (MERS-CoV)

   (2015) (WHO, Geneva (CH)) Avaliable from: http://www.who.int/emergencies/mers-cov/en/.
4. ↵
   1. Al-Tawfiq JA,
   2. Assiri A,
   3. Memish ZA

   (2013) Middle East respiratory syndrome novel corona MERS-CoV infection. Epidemiology and outcome update. Saudi Med J 34:991–994.

   OpenUrlPubMedWeb of Science
5. ↵
   1. Arabi YM,
   2. Arifi AA,
   3. Balkhy HH,
   4. Najm H,
   5. Aldawood AS,
   6. Ghabashi A,
   7. et al.

   (2014) Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome corona virus infection. Ann Intern Med 160:389–397.

   OpenUrlCrossRefPubMedWeb of Science
6. ↵
   1. Raj VS,
   2. Mou H,
   3. Smits SL,
   4. Dekkers DH,
   5. Müller MA,
   6. Dijkman R,
   7. et al.

   (2013) Dipeptidyl peptidase 4 is a functional receptor for the emerging human corona virus-EMC. Nature 495:251–254.

   OpenUrlCrossRefPubMedWeb of Science
7. ↵
   1. Lamers D,
   2. Famulla S,
   3. Wronkowitz N,
   4. Hartwig S,
   5. Lehr S,
   6. Ouwens DM,
   7. et al.

   (2011) Dipeptidyl peptidase 4 is a novel adipokine ptenially linking obesity to the metabolic syndrome. Diabetes 60:1917–1925.

   OpenUrlAbstract/FREE Full Text
8. ↵
   1. Barnett A

   (2006) DPP-4 inhibitors and their potential role in the management of type 2 diabetes. Int J Clin Pract 60:1454–1470.

   OpenUrlCrossRefPubMedWeb of Science
9. ↵
   1. Gu J,
   2. Gong E,
   3. Zhang B,
   4. Zheng J,
   5. Gao Z,
   6. Zhong Y,
   7. et al.

   (2005) Multiple organ infection and the pathogenesis of SARS. J Exp Med 202:415–24.

   OpenUrlAbstract/FREE Full Text
10. ↵
    1. Xu J,
    2. Zhong S,
    3. Liue J,
    4. Li L,
    5. Li Y,
    6. Wu X,
    7. et al.

    (2005) Detection of severe acute respiratory syndrome corona virus in the brain: potential role of the chemoking mig in pathogenesis. Clin Infect Dis 41:1089–1096.

    OpenUrlCrossRefPubMedWeb of Science
11. ↵
    1. Falzarano D,
    2. de Wit E,
    3. Rasmussen AL,
    4. Feldmann F,
    5. Okumura A,
    6. Scott DP,
    7. et al.

    (2013) Treatment with interferon-alph2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques. Nat Med 19:1313–1317.

    OpenUrlCrossRefPubMed
12. ↵
    1. Arabi YM,
    2. Harthi A,
    3. Hussein J,
    4. Bouchama A,
    5. Johani S,
    6. Hajeer AH,
    7. et al.

    (2015) severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV). Infection 43:495–501.

    OpenUrlCrossRefPubMed